2024
Rethinking the Abnormal Uterine Bleeding Consult: Creating a Patient-Centered, See-and-Treat Model of Care
Robinson E, Desai V, Chudnoff S. Rethinking the Abnormal Uterine Bleeding Consult: Creating a Patient-Centered, See-and-Treat Model of Care. 2024, 1: 008. DOI: 10.1097/og9.0000000000000008.Peer-Reviewed Original ResearchAbnormal uterine bleedingPatient-centeredEvaluation of abnormal uterine bleedingClinical care modelsHealth care efficiencyAssessed patients' historyPhysician engagementUterine assessmentCare modelUterine bleedingCare settingsPatient experienceGynecologic conditionsCare efficiencyOutpatient procedureIn-officePatient historyOutpatient settingCoronavirus disease 2019Operating roomClinical practiceLearning curveCareCOVID-19COVID-19 pandemic
2017
Utilization of gynecologic services in women with breast cancer receiving hormonal therapy
Wright JD, Desai VB, Chen L, Burke WM, Tergas AI, Hou JY, Accordino M, Ananth CV, Neugut AI, Hershman DL. Utilization of gynecologic services in women with breast cancer receiving hormonal therapy. American Journal Of Obstetrics And Gynecology 2017, 217: 59.e1-59.e12. PMID: 28341383, PMCID: PMC5499703, DOI: 10.1016/j.ajog.2017.03.011.Peer-Reviewed Original ResearchConceptsAromatase inhibitorsBreast cancerHormonal therapyPostmenopausal womenGynecologic symptomsCumulative incidenceGynecologic proceduresLimited population-level dataSurveillance testingSelective estrogen receptor modulator tamoxifenEstrogen receptor modulator tamoxifenStudy periodPopulation-based analysisYears of agePopulation-level dataTamoxifen useAsymptomatic womenGynecologic problemsMarketScan databaseGynecologic conditionsPathologic diagnosisGynecologic abnormalitiesGynecologic servicesGynecologic interventionsTamoxifen